Despite previous studies on the reduced expression of the PU.1 gene in the CML patients, the direct investigation of PU.1 mRNA level in the blood samples of the ALL patients was not performed  16, 17 . This evidence concerns the gene SPI1 and chronic myelogenous leukemia, BCR-ABL1 positive.